COMPANY PROFILE

InBiome

Explore full profile

Radically accelerating human healthcare

Amsterdam, NetherlandsFounded 2019Biotech & Life Sciences

Valuation $50–100M Last recorded · 2026

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About InBiome

Developer of fiber optic technology designed for internet service providers to offer effective gigabit fiber-optic internet connections at reasonable costs and with low power consumption. The company's technology offers effective fiber-optic signals invented a novel method, that can improve data rate and reach a much lower cost than full coherent. allow internet providers to upgrade their networks in a plug-and-play solution, to meet their customers' needs. Keywords: Pharmaceuticals and Biotechnology, Detection Device, Healthcare Technology, Microbiology Services, Molecular Technology, Molecular Technology Platform, Molecular Tools Developer.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2019
Headquarters: Amsterdam, Netherlands
Employees: 25
Open positions: None listed
Dealroom signal: 71.9/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices, Health Platform
Sector: Biotech & Life Sciences, Biotechnology, Pathology
Technology: Artificial Intelligence, Hardware, Big Data, Machine Learning, Deep Learning
Business model: Manufacturing, SaaS
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Apr 2026	$16M	$64M	Slingshot Ventures · NATO Innovation Fund - NIF	↗
GRANTOther financing	Mar 2023	$2.8M	—	European Commission	↗

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

InBiome website traffic

Latest recorded traffic for InBiome is 2K monthly website visits, down 50% over the last three months. InBiome's team grew 13.6% over the past year.

Latest monthly visits2K 3-month web change-50% 1-year team growth+13.6%

Monthly website visitsMar 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ILiLoFAI and photonics platform for personalized drug discovery.	London, United Kingdom	Operational	40	$13M	$22M
DXDxCoverDeveloping a spectroscopic liquid biopsy for rapid detection of cancer	Glasgow, United Kingdom	Operational
NENeuroCluesThe brain stethoscope providing CNS biomarkers in a Blink	Ottignies-Louvain-la-Neuve, Belgium	Operational
MIMindPeakMindPeak automates visual diagnosis, making microscopical analysis more accessible to support in accurate cancer diagnoses	Hamburg, Germany	Operational
INInnitiusCervical Consistency + AI for improved accuracy in Birth Timing	Derio, Spain	Operational
ATArctic TherapeuticsTransforming drug discovery and development by harnessing the power of applied of genomics	Reykjavík, Iceland	Operational
CTCeleris TherapeuticsPredicting biomolecular interactions and designing drugs for incurable diseases	Graz, Austria	Operational
RARadioboticsAutomating routine tasks, alleviating the urgent need for specialized radiologists, whilst improving diagnostic quality	Copenhagen, Denmark	Acquired